Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

4:09 PM ET 8-K
Loan & Debt Science Applications International Corp SAIC

Science Applications International $500M Debt Financing with Truist Bank

Science Applications International Corporation (SAIC) closed a private offering of $500 million in 6.750% Senior Notes due 2034. The company used the net proceeds of approximately $493 million to redeem its outstanding 4.875% Senior Notes due 2028 and for general corporate purposes.

Value
$500M
Counterparty
Truist Bank
Term
through 2034
4:09 PM ET 10-Q
Financial Results OptimizeRx Corp OPRX

OptimizeRx Q3 2026 Results: Net Income $1.2M, Up 53.4% YoY

For the three months ended September 30, 2026, OptimizeRx reported net revenue of $21.6 million and net income of $1.2 million, compared to $26.1 million and $0.8 million in the prior year period. While quarterly profitability improved, the company recorded a slight net loss of $3,000 for the nine-month period as revenues declined from $77.2 million to $62.0 million year-over-year.

Key figure
Net income $1.2M · +53.4% YoY
4:09 PM ET 8-K
Financial Results Vistagen Therapeutics, Inc. VTGN

Vistagen Therapeutics Financial Results

Vistagen reported financial results for its fiscal year 2027 second quarter ended September 30, 2026, and provided a corporate update on its fasedienol Phase 3 development plan for social anxiety disorder. The company highlighted constructive FDA feedback regarding its clinical trial design and the appointment of Dr. Douglas J. Williamson to its Board of Directors. Vistagen also implemented cost-management initiatives to prioritize capital for its late-stage neuroscience programs.

Term
Q2 2027

“Following our recent productive meeting with the FDA and our evaluation of the extensive body of efficacy, safety, and patient experience data generated throughout Phase 2 and Phase 3 development of fasedienol, we believe we have clarity on the potential regulatory pathways forward for fasedienol in social anxiety disorder”

Shawn Singh, President and Chief Executive Officer of Vistagen

“Recent alignment of our operating structure and capital resources with our late-stage development opportunities in both social anxiety disorder and menopausal hot flashes, position us to execute our plan to advance these programs while maintaining flexibility to create long-term shareholder value.”

Shawn Singh, President and Chief Executive Officer of Vistagen
4:09 PM ET 10-Q
Financial Results Werewolf Therapeutics, Inc. HOWL

Werewolf Therapeutics Q3 2026 Results: Net Loss of $9.88M, Loss Narrows

Werewolf Therapeutics is currently pursuing a merger with Ambros and a concurrent PIPE financing to address substantial doubt about its ability to continue as a going concern. As of November 9, 2026, the company had 48,599,066 shares of common stock outstanding and is evaluating strategies to raise additional capital to fund its research and development programs.

Key figure
Net loss $9.88M
4:08 PM ET 8-K
Financial Results Inhibrx Biosciences, Inc. INBX

Inhibrx Biosciences Financial Results

Inhibrx Biosciences reported Q3 2026 financial results, highlighting a cash position of $199.5 million and $2.0 million in revenue from a licensing agreement with Pfizer. The company is advancing its clinical pipeline, with upcoming data presentations for ozekibart in Ewing sarcoma and ongoing enrollment in the Phase 2 HexAgon study for ordastobart.

Term
Q3 2026
4:08 PM ET 10-Q
Financial Results Republic Digital Acquisition Co RDAG

Republic Digital Acquisition Q3 2026 Results: Net Income $2.75M, Down 11.2% YoY

Republic Digital Acquisition Company is a special purpose acquisition company (SPAC) that reported 30,000,000 Class A and 7,500,000 Class B ordinary shares outstanding as of November 13, 2026. The company's cash position decreased from $1,016,713 at the end of 2025 to $643,377 as of September 30, 2026, as it continues to seek an initial business combination within its designated 24-month period.

Key figure
Net income $2.75M · -11.2% YoY
4:08 PM ET 10-Q
Financial Results Royalty Management Holding Corp RMCO

Royalty Management Holding Q3 2026 Results: Turns Profitable, Net Income $19.5K

For the nine months ended September 30, 2026, Royalty Management Holding Corp reported total revenue of $5.63 million, a significant increase from $3.55 million in the prior year, primarily driven by environmental services. Despite the revenue growth, the company realized a net loss of $257,687 for the period, though this was an improvement over the $317,131 net loss reported in the same period of 2025.

Key figure
Net income $19.5K
4:08 PM ET 10-Q
Financial Results Adaptin Bio, Inc. APTN

Adaptin Bio Q3 2026 Results: Net Loss of $957K, Loss Narrows

Adaptin Bio, Inc. reported a net loss of $3.31 million for the nine months ended September 30, 2026, compared to a $3.80 million loss in the prior year period. The company remains in the development stage with no revenue, maintaining a stockholders' deficit of $1.67 million and a cash balance of $430,333 as of the reporting date.

Key figure
Net loss $957K
4:08 PM ET 10-Q
Financial Results Digimarc Corp DMRC ▶ Call

Digimarc Q3 2026 Results: Net Loss of $8.09M, Loss Narrows

Digimarc reported a total revenue of $6.4 million for the third quarter of 2026, a decrease from $7.6 million in the prior year, primarily driven by lower subscription revenue. The company's net loss narrowed slightly to $7.9 million for the quarter, while cash and cash equivalents increased to $20.7 million as of September 30, 2026.

Key figure
Net loss $8.09M
4:08 PM ET 10-Q
Financial Results HWH International Inc. ESYN

EnerSyn Global Q3 2026 Results: Net Loss of $3M, Loss Widens

EnerSyn Global Inc. reported a significant increase in total assets to $17.8 million as of September 30, 2026, driven by a substantial cash infusion and common stock issuances. However, the company experienced a widened net loss of $3.4 million for the nine months ended September 30, 2026, primarily due to a sharp rise in general and administrative expenses.

Key figure
Net loss $3M
4:08 PM ET 10-Q
Financial Results Rocket One Inc. RKTO

Rocket One Q3 2026 Results: Net Loss of $2.68M, Loss Narrows

Rocket One Inc. reported a total asset increase to $8.66 million as of September 30, 2026, driven by new intangible assets and goodwill, despite a decrease in cash and cash equivalents. The company's accumulated deficit grew to $82.09 million, reflecting ongoing operational losses during its strategic repositioning into orbital and defense technologies.

Key figure
Net loss $2.68M
4:08 PM ET Form 4
Insider Selling Ibotta, Inc. IBTA

Ibotta 10% Owner KDT Ibotta Holdings LLC Sells $16.4M of Stock

KDT Ibotta Holdings LLC, 10% Owner, sold 274,999 shares of Ibotta, Inc. at $58.97 to $59.97 a share (average $59.55) in 4 transactions, worth $16.4M in total between Nov 11, 2026 and Nov 12, 2026. Shares held after the trade: 3,014,129 (-3.2%).

Value
$16.4M
Shares
274,999
Average price
$59.55
Role
10% Owner
Holding change
-3.2%
Trade date
Nov 11, 2026 to Nov 12, 2026
4:08 PM ET 10-Q
Financial Results Bryn Inc. MDTK

Medo Technologies Q3 2026 Results: Net Loss of $191K, Loss Widens

MEDO Technologies, Inc. reported a net loss of $191,301 for the three months ended September 30, 2026, and a cumulative net loss of $400,884 for the nine-month period. The company remains in a deficit position with total stockholders' deficit of $395,563 and implemented a 1-for-100,000 reverse stock split effective September 23, 2026.

Key figure
Net loss $191K
4:08 PM ET 8-K
Leadership Change Ethan Allen Interiors Inc ETD

Ethan Allen Interiors Leadership Change

M. Farooq Kathwari has resigned as President and CEO of Ethan Allen, effective immediately. The Board has appointed Stefanie T. Ward as Interim CEO for a six-month term and expanded the Board of Directors with four new appointments, including Anna Brockway and Steve Oblak, to oversee a strategic reset of the company.

Term
6 months
4:08 PM ET Form 4
Insider Buying Hudson Pacific Properties, Inc. HPP

Hudson Pacific Properties President Mark T. Lammas Buys $43.6K of Stock

Mark T. Lammas, President, bought 5,000 shares of Hudson Pacific Properties, Inc. at $8.73 a share, worth $43.6K in total on Nov 12, 2026. Shares held after the trade: 25,225 (+24.7%).

Value
$43.6K
Shares
5,000
Price
$8.73
Role
President
Holding change
+24.7%
Trade date
Nov 12, 2026
4:08 PM ET 8-K
Loan & Debt BWX Technologies, Inc. BWXT

BWX Technologies $500M Debt Financing with U.S. Bank Trust Company, National Association

BWX Technologies issued $500 million of 6.500% Senior Notes due 2034 in a private placement. The proceeds were used to fund a tender offer and consent solicitation to purchase and amend its existing 4.125% Senior Notes due 2028 and 2029, effectively refinancing its near-term debt.

Value
$500M
Counterparty
U.S. Bank Trust Company, National Association
Term
10 years
4:08 PM ET 10-Q
Financial Results Columbus Circle Capital Corp III CCCT

Columbus Circle Capital Corp III Q3 2026 Results: Turns Profitable, Net Income $1.58M

Columbus Circle Capital Corp III is a shell company that completed its IPO on July 10, 2026, raising $230 million held in a trust account. As of September 30, 2026, the company has 23,665,000 Class A and 7,666,667 Class B ordinary shares outstanding and is seeking a business combination within a 24-month period.

Key figure
Net income $1.58M
4:08 PM ET 10-Q
Financial Results SmartKem, Inc. SMTK

SmartKem Q3 2026 Results: Net Loss of $1.52M, Loss Narrows

SmartKem, Inc. reported a net loss of $24.1 million for the nine months ended September 30, 2026, significantly impacted by a $45.6 million loss on the write-off of bad debts and $11.9 million in ELOC commitment share expenses. Despite these losses, the company improved its balance sheet through debt-to-equity conversions and preferred stock issuances, ending the period with $4.3 million in cash and total stockholders' equity of $12.8 million.

Key figure
Net loss $1.52M
4:08 PM ET 10-Q
Financial Results Our Bond, Inc. OBAI

Our Bond Q3 2026 Results: Net Loss of $4.67M, Loss Widens

Our Bond, Inc. reported a significant increase in net loss to $16.1 million for the nine months ended September 30, 2026, compared to $7.8 million in the prior year, driven by a doubling of operating expenses. Revenue slightly declined to $6.98 million, while the company maintained a stockholders' deficit of $16.97 million.

Key figure
Net loss $4.67M
4:08 PM ET 10-Q
Financial Results Cero Therapeutics Holdings, Inc. CERO

Cero Therapeutics Holdings Q3 2026 Results: Turns Profitable, Net Income $4.02M

CERo Therapeutics Holdings, Inc. is an emerging growth company focused on developing its lead product candidate, CER-1236. As of November 13, 2026, the company reported 83,309,742 shares of common stock outstanding and noted the impact of its delisting from Nasdaq as a significant risk factor.

Key figure
Net income $4.02M
4:08 PM ET 10-Q
Financial Results Cifc Direct Lending Evergreen Fund

Cifc Direct Lending Evergreen Fund Q3 2026 Results: Net Income $1.64M, Down 54.2% YoY

For the nine months ended September 30, 2026, CIFC Direct Lending Evergreen Fund reported total investment income of $22.8 million and net investment income of $10.3 million. Total net assets grew to $112.1 million, supported by $11.0 million in net increase from operations and $9.0 million in capital contributions, partially offset by $9.9 million in distributions and redemptions.

Key figure
Net income $1.64M · -54.2% YoY
4:08 PM ET 8-K
Financial Results OptimizeRx Corp OPRX

OptimizeRx Financial Results

OptimizeRx reported Q3 2026 revenue of $21.6 million, a 17% year-over-year decrease, while GAAP net income rose to $1.2 million. The company updated its full-year 2026 revenue guidance to $87-$93 million but maintained its adjusted EBITDA outlook. Management highlighted significant margin expansion and a reduction in debt principal to $10.4 million.

Term
Q3 2026

“Third quarter revenue and adjusted EBITDA both exceeded consensus expectations, reflecting continued margin expansion, disciplined execution, and the resilience of our operating model. While revenue declined year-over-year, adjusted EBITDA increased approximately 23%, with adjusted EBITDA margins expanding over 900 basis points, demonstrating the benefits of our improved product mix and cost management initiatives.”

Stephen L. Silvestro, OptimizeRx CEO

“While in-year contracted revenue continues to track below prior-year levels, resulting in a revision to our full-year 2026 revenue outlook, we remain encouraged by the growth we are seeing in contracted revenue for 2027, highlighting a start to a strong RFP season.”

Stephen L. Silvestro, OptimizeRx CEO
4:08 PM ET 8-K
Investor Presentation Texas Capital Bancshares Inc TXCP

Texas Capital Bancshares Investor Presentation

Texas Capital Bancshares, Inc. furnished a formal presentation deck titled 'Annual Governance Discussion Materials 2026' as part of its stockholder engagement program. The materials cover the company's governance structure, strategic plans, and financial condition for discussion with stockholders and other constituents.

4:07 PM ET Form 4
Insider Selling Upland Software, Inc. UPLD

Upland Software Insider John T. Mcdonald Sells $47.4K of Stock

John T. Mcdonald sold 15,000 shares of Upland Software, Inc. at $3.16 a share, worth $47.4K in total on Nov 11, 2026. Shares held after the trade: 249,088 (-5.7%).

Value
$47.4K
Shares
15,000
Price
$3.16
Holding change
-5.7%
Trade date
Nov 11, 2026
4:07 PM ET 8-K
Nasdaq/NYSE Compliance Notice PSQ Holdings, Inc. PSQH

PSQ Holdings Nasdaq/NYSE Compliance Notice

The NYSE has commenced proceedings to delist PSQ Holdings' Class A common stock and public warrants after the company failed to maintain a minimum average global market capitalization of $15 million. Trading on the NYSE was suspended immediately on November 9, 2026, and the securities transitioned to the Pink Limited Market. The company does not intend to appeal the delisting determination and is seeking a listing on the OTCQB Venture Market.

Counterparty
New York Stock Exchange
4:07 PM ET 8-K/A
Leadership Change Borgwarner Inc BWA

Borgwarner Leadership Change

BorgWarner Inc. filed an amendment to a previous 8-K to disclose the committee assignments for Rajesh Kalathur, who was appointed to the Board of Directors on July 30, 2026. The Board has now appointed Mr. Kalathur to serve as a member of the Audit Committee, effective November 11, 2026.

4:07 PM ET 10-Q
Financial Results FB Bancorp, Inc. FBLA

FB Bancorp Q3 2026 Results: Net Income $466K, Down 56.9% YoY

For the nine months ended September 30, 2026, FB Bancorp reported net income of $515 thousand, a significant decrease from $2.66 million in the prior year period, primarily due to a $1.14 million loss from discontinued operations and increased non-interest expenses. Total assets decreased to $1.21 billion from $1.26 billion at year-end 2025, while stockholders' equity was impacted by $32.3 million in common stock repurchases.

Key figure
Net income $466K · -56.9% YoY
4:07 PM ET 10-Q
Financial Results Yorkville International Capital Corp. YICC

Yorkville International Capital Q3 2026 Results: Net Income $1.82M

Yorkville International Capital Corp. is a special purpose acquisition company (SPAC) that completed its IPO on June 17, 2026, raising $230 million held in a trust account. As of September 30, 2026, the company is in its search phase for an initial business combination and reported 23,000,000 Class A and 15,333,333 Class B ordinary shares outstanding.

Key figure
Net income $1.82M
4:07 PM ET 10-Q
Financial Results TRG Latin America Acquisitions Corp. TRGS

TRG Latin America Acquisitions Q3 2026 Results: Net Income $1.81M

TRG Latin America Acquisitions Corp. is a special purpose acquisition company (SPAC) that completed its IPO on February 27, 2026, raising proceeds for a trust account totaling $210,677,645 as of September 30, 2026. The company is currently in its combination period with a deadline of February 27, 2028, to consummate an initial business combination.

Key figure
Net income $1.81M
4:07 PM ET 8-K
Leadership Change Ipalco Enterprises, Inc.

Ipalco Enterprises Leadership Change

John Christopher Shelton was elected to the Board of Directors of IPALCO Enterprises, Inc. to fill a vacancy. Mr. Shelton, who currently serves as Senior Vice President and Chief Product Officer of The AES Corporation, was nominated by AES U.S. Investments, Inc. pursuant to a shareholders' agreement. He will not receive separate compensation for his service on the IPALCO Board.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.